Research
Energy balance
Tirzepatide (TZP) resulted in a mean body weight loss of 16.7 kg compared to 8.3 kg with placebo (PBO) after 18 weeks (p<0.001).
Tirzepatide may be an effective treatment for weight loss in individuals with obesity.
StrongSupportsmedium confidence
At 18wk, mean body weight loss was 16.7 kg with TZP and 8.3 kg with PBO (p<0.001).
Why this rating
Based on a randomized blinded clinical trial design.
Source
128-OR: The Effect of Tirzepatide during Weight Loss on Food Intake, Appetite, Food Preference, and Food Craving in People with Obesity
CORBY K. MARTIN et al. · Diabetes · 2023
rct · n=55Cited 20×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →